
S0668 Time to Improvement in Patient-Reported Outcomes With Tofactinib in Ulcerative Colitis: Initial Results From a Real World Prospective Multicenter Study (TOUR)
Author(s) -
Millie D. Long,
Maisa Abdalla,
Anita Afzali,
Robert P. McCabe,
Benjamin Cohen,
Monika Fischer,
William R. Harlan,
John S. Hanson,
David Hudesman,
Gauree G. Konijeti,
Steven Polyak,
Timothy E. Ritter,
Bruce Salzberg,
Emily English,
Hans Herfarth
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000704720.99780.b3
Subject(s) - medicine , tofacitinib , ulcerative colitis , depression (economics) , anxiety , prospective cohort study , population , quality of life (healthcare) , janus kinase inhibitor , physical therapy , concomitant , patient reported outcome , patient reported outcomes measurement information system , disease , psychiatry , psychometrics , clinical psychology , rheumatoid arthritis , computerized adaptive testing , nursing , environmental health , economics , macroeconomics